“Validity and Reability Test of the Naranjo Questionnaire to Measure Adverse Drug Reactions (ADRs) in Atherosclerosis Patients” (2026) Biocity Journal of Pharmacy Bioscience and Clinical Community, 4(2), pp. 43–50. doi:10.30812/biocity.v4i2.5842.